The novel proteasome inhibitor NPI-0052 plus TRAIL (TNF related apoptosis inducing ligand) activates the extrinsic apoptotic pathway in pancreatic cancer

被引：0
|
作者：
Sundi, D. [1 ]
Fournier, K. [1 ]
Wray, C. [1 ]
McConkey, D. [1 ]
机构：
[1] MD Anderson Canc Ctr, Houston, TX USA
来源：
ANNALS OF SURGICAL ONCOLOGY | 2008年 / 15卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：70 / 71
页数：2
相关论文
共 50 条
  • [31] Should We Keep Walking along the Trail for Pancreatic Cancer Treatment? Revisiting TNF-Related Apoptosis-Inducing Ligand for Anticancer Therapy
    Kretz, Anna-Laura
    von Karstedt, Silvia
    Hillenbrand, Andreas
    Henne-Bruns, Doris
    Knippschild, Uwe
    Trauzold, Anna
    Lemke, Johannes
    CANCERS, 2018, 10 (03)
  • [32] SAHA-sensitized prostate cancer cells to TNFα-related apoptosis-inducing ligand (TRAIL):: Mechanisms leading to synergistic apoptosis
    Lakshmikanthan, Vijavabaskar
    Kaddour-Djebbar, Ismail
    Lewis, Ronald W.
    Kumar, M. Vijay
    INTERNATIONAL JOURNAL OF CANCER, 2006, 119 (01) : 221 - 228
  • [33] TNF-related apoptosis-inducing ligand (TRAIL) blocks osteoclastic differentiation induced by RANKL plus M-CSF
    Zauli, G
    Rimondi, E
    Nicolin, V
    Melloni, E
    Celeghini, C
    Secchiero, P
    BLOOD, 2004, 104 (07) : 2044 - 2050
  • [34] MEDI3039, a novel highly potent tumor necrosis factor (TNF)-related apoptosis inducing ligand (TRAIL) receptor agonist, induces apoptotic cell death in breast cancer cells
    Greer, Y. E.
    Tice, D.
    Lipkowitz, S.
    CANCER RESEARCH, 2016, 76
  • [35] Neutrophil-derived TNF-related apoptosis-inducing ligand (TRAIL): A novel mechanism of antitumor effect by neutrophils
    Koga, Y
    Matsuzaki, A
    Suminoe, A
    Hattori, H
    Hara, T
    CANCER RESEARCH, 2004, 64 (03) : 1037 - 1043
  • [36] RETRACTED: Inhibition of Yin Yang 1-dependent repressor activity of DR5 transcription and expression by the novel proteasome inhibitor NPI-0052 contributes to its TRAIL-enhanced apoptosis in cancer cells (Retracted Article. See vol 197, pg 4860, 2016)
    Baritaki, Stavroula
    Suzuki, Eriko
    Umezawa, Kazuo
    Spandidos, Demetrios A.
    Berenson, James
    Daniels, Tracy R.
    Penichet, Manuel L.
    Jazirehi, Ali R.
    Palladino, Michael
    Bonavida, Benjamin
    JOURNAL OF IMMUNOLOGY, 2008, 180 (09): : 6199 - 6210
  • [37] Chrysin promotes tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) induced apoptosis in human cancer cell lines
    Li, Xin
    Wang, Jian-Ning
    Huang, Jun-Ming
    Xiong, Xi-Kun
    Chen, Mei-Fen
    Ong, Choon-Nam
    Shen, Han-Ming
    Yang, Xing-Fen
    TOXICOLOGY IN VITRO, 2011, 25 (03) : 630 - 635
  • [38] Vemurafenib may overcome TNF-related apoptosis-inducing ligand (TRAIL) resistance in anaplastic thyroid cancer cells
    Tania Pilli
    Silvia Cantara
    Carlotta Marzocchi
    Furio Pacini
    Bellur S. Prabhakar
    Maria Grazia Castagna
    Endocrine, 2020, 67 : 117 - 123
  • [39] Vemurafenib may overcome TNF-related apoptosis-inducing ligand (TRAIL) resistance in anaplastic thyroid cancer cells
    Pilli, Tania
    Cantara, Silvia
    Marzocchi, Carlotta
    Pacini, Furio
    Prabhakar, Bellur S.
    Castagna, Maria Grazia
    ENDOCRINE, 2020, 67 (01) : 117 - 123
  • [40] Cellular inhibitor of apoptosis 1 (cIAP-1) degradation by caspase 8 during TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis
    Guicciardi, Maria Eugenia
    Mott, Justin L.
    Bronk, Steven F.
    Kurita, Satoshi
    Fingas, Christian D.
    Gores, Gregory J.
    EXPERIMENTAL CELL RESEARCH, 2011, 317 (01) : 107 - 116
12345